Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective Study

Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective Study

The lack of invasive pneumococcal disease (IPD) cost studies may underestimate the eect of<br />pneumococcal polysaccharide conjugated vaccines (PCV). The objective of this study was to estimate<br />the direct costs of hospitalized IPD cases. A prospective study was made in children age...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Sergi Hernández, Encarna Navas, Ignacio Aznar-Lou, Pilar Ciruela, Juan José García-García, Fernando Moraga-Llop, Carmen Muñoz-Almagro, Gemma Codina, Mariona F. de Sevilla, Sebastià González-Peris, Cristina Esteva, Ana María Planes, Conchita Izquierdo, Johanna Martínez-Osorio, Magda Campins, Sonia Uriona, Luis Salleras, Antoni Serrano-Blanco, Mireia Jané, Ángela Domínguez
Format: Artikel
Sprache:English
Veröffentlicht: MDPI AG 2020-07-01
Schriftenreihe:Vaccines
Schlagworte:
PCV7
PCV13
invasive pneumococcal disease
direct cost
Online Zugang:https://www.mdpi.com/2076-393X/8/3/387

Online

https://www.mdpi.com/2076-393X/8/3/387

Ähnliche Einträge